"O IBPClin um Centro de Pesquisa Clínica, dedicado à condução de grandes estudos multicêntricos para desenvolvimento de novos medicamentos para a indústria farmacêutica."

During the past decade, CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 16 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." #1 sponsor was "Pfizer" with 5 trials, followed by "Mannkind Corporation" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "R-Pharm International, LLC" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." are "Arthritis, Rheumatoid" (4 trials), "Diabetes Mellitus, Type 2" (4 trials), "Rheumatoid Arthritis" (3 trials), "Cardiovascular Disease" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." in a lesser frequency.

Most popular intervention types in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." are "Drug" (21 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Technosphere Insulin" (3 trials), "CP-690,550" (2 trials), "Empagliflozin" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda." are 21 trials for "All" genders.

Currently, there are NaN active trials in "CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CCBR Brasil Centro de Pesquisas e Análises Clínicas Ltda., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".